Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Intravenous Iron Therapy in Gastric Cancer
NCT04168346Phase 4Not yet recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Nov 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Helsinki University Hospital. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04168346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04168346.